Literature DB >> 30765505

Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests.

Marko Topalovic1, Nilakash Das1, Pierre-Régis Burgel2, Marc Daenen3, Eric Derom4, Christel Haenebalcke5, Rob Janssen6, Huib A M Kerstjens7, Giuseppe Liistro8, Renaud Louis9, Vincent Ninane10, Christophe Pison11, Marc Schlesser12, Piet Vercauter13, Claus F Vogelmeier14, Emiel Wouters15, Jokke Wynants16,17, Wim Janssens1.   

Abstract

The interpretation of pulmonary function tests (PFTs) to diagnose respiratory diseases is built on expert opinion that relies on the recognition of patterns and the clinical context for detection of specific diseases. In this study, we aimed to explore the accuracy and interrater variability of pulmonologists when interpreting PFTs compared with artificial intelligence (AI)-based software that was developed and validated in more than 1500 historical patient cases.120 pulmonologists from 16 European hospitals evaluated 50 cases with PFT and clinical information, resulting in 6000 independent interpretations. The AI software examined the same data. American Thoracic Society/European Respiratory Society guidelines were used as the gold standard for PFT pattern interpretation. The gold standard for diagnosis was derived from clinical history, PFT and all additional tests.The pattern recognition of PFTs by pulmonologists (senior 73%, junior 27%) matched the guidelines in 74.4±5.9% of the cases (range 56-88%). The interrater variability of κ=0.67 pointed to a common agreement. Pulmonologists made correct diagnoses in 44.6±8.7% of the cases (range 24-62%) with a large interrater variability (κ=0.35). The AI-based software perfectly matched the PFT pattern interpretations (100%) and assigned a correct diagnosis in 82% of all cases (p<0.0001 for both measures).The interpretation of PFTs by pulmonologists leads to marked variations and errors. AI-based software provides more accurate interpretations and may serve as a powerful decision support tool to improve clinical practice.
Copyright ©ERS 2019.

Entities:  

Year:  2019        PMID: 30765505     DOI: 10.1183/13993003.01660-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

1.  Artificial Intelligence in COPD: New Venues to Study a Complex Disease.

Authors:  Raúl San José Estépar
Journal:  Barc Respir Netw Rev       Date:  2020 May-Dec

2.  Reconciling Allergy Information in the Electronic Health Record After a Drug Challenge Using Natural Language Processing.

Authors:  Ying-Chih Lo; Sheril Varghese; Suzanne Blackley; Diane L Seger; Kimberly G Blumenthal; Foster R Goss; Li Zhou
Journal:  Front Allergy       Date:  2022-05-10

3.  Explainable machine learning methods and respiratory oscillometry for the diagnosis of respiratory abnormalities in sarcoidosis.

Authors:  Allan Danilo de Lima; Agnaldo J Lopes; Jorge Luis Machado do Amaral; Pedro Lopes de Melo
Journal:  BMC Med Inform Decis Mak       Date:  2022-10-20       Impact factor: 3.298

Review 4.  A scoping review of artificial intelligence applications in thoracic surgery.

Authors:  Kenneth P Seastedt; Dana Moukheiber; Saurabh A Mahindre; Chaitanya Thammineni; Darin T Rosen; Ammara A Watkins; Daniel A Hashimoto; Chuong D Hoang; Jacques Kpodonu; Leo A Celi
Journal:  Eur J Cardiothorac Surg       Date:  2022-01-24       Impact factor: 4.191

5.  Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Respir Med       Date:  2020-06       Impact factor: 30.700

6.  Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?

Authors:  Paresh C Giri; Anand M Chowdhury; Armando Bedoya; Hengji Chen; Hyun Suk Lee; Patty Lee; Craig Henriquez; Neil R MacIntyre; Yuh-Chin T Huang
Journal:  Front Physiol       Date:  2021-06-24       Impact factor: 4.566

Review 7.  Machine Learning for Pulmonary and Critical Care Medicine: A Narrative Review.

Authors:  Eric Mlodzinski; David J Stone; Leo A Celi
Journal:  Pulm Ther       Date:  2020-02-05

8.  Performance of Qure.ai automatic classifiers against a large annotated database of patients with diverse forms of tuberculosis.

Authors:  Eric Engle; Andrei Gabrielian; Alyssa Long; Darrell E Hurt; Alex Rosenthal
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

9.  Automated Smart Home Assessment to Support Pain Management: Multiple Methods Analysis.

Authors:  Roschelle L Fritz; Marian Wilson; Gordana Dermody; Maureen Schmitter-Edgecombe; Diane J Cook
Journal:  J Med Internet Res       Date:  2020-11-06       Impact factor: 5.428

Review 10.  Artificial Intelligence and Machine Learning in Chronic Airway Diseases: Focus on Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Yinhe Feng; Yubin Wang; Chunfang Zeng; Hui Mao
Journal:  Int J Med Sci       Date:  2021-06-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.